Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Alopecia areata · Multiple myeloma

First Biotech (Australia)

Pfizer Australia Pty Ltd

First Biotech (Australia) clinical programs — 40 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Norwest House, 710 Collins Street, Melbourne, VIC 3008, AU HQ
2017 Founded
2 Employees
TGA registrant Type
Company details
Status
Public
HQ
Norwest House, 710 Collins Street, Melbourne, VIC 3008, AU
Founded
2017
Employees
2
Programs
126
Drugs
208
Patents
0
Official website ↗ All projects Drug pipeline News & analysis
Intelligence · Clinical Programs

First Biotech (Australia) projects

40 ClinicalTrials.gov programs sponsored by First Biotech (Australia).

First Biotech (Australia) has 40 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

40 programs

Clinical programs

  1. A Study of PF-08046031 in Adults With Advanced Melanoma and Other Solid Tumors

    Pfizer Australia Pty Ltd

    Melanoma (or) malignant melanoma Non-small cell lung cancer Head and neck squamous cell carcinoma Esophageal cancer

    phase 1 other active

    1 trial

  2. A Study to Learn If the Study Medicine Called...

    Pfizer Australia Pty Ltd

    ER+/HER2 positive breast cancer

    phase 1 other active

    1 trial

  3. A0281007

    Pfizer Australia Pty Ltd

    Primary and secondary hypertension, and heart failure

    phase 1 other active

    1 trial

  4. A6281331

    Pfizer Australia Pty Ltd

    Growth hormone deficiency

    phase 1 other active

    1 trial

  5. A6791042

    Pfizer Australia Pty Ltd

    long-term female contraception

    phase 1 other active

    1 trial

  6. B3461114

    Pfizer Australia Pty Ltd

    aransthyretin amyloid cardiomyopathy

    phase 1 small molecule active

    1 trial

  7. B3461115

    Pfizer Australia Pty Ltd

    Transthyretin amyloidosis

    phase 1 other active

    1 trial

  8. B3461131

    Pfizer Australia Pty Ltd

    Transthyretin amyloidosis

    phase 1 other active

    1 trial

  9. C2321001

    Pfizer Australia Pty Ltd

    Castration Resistant Prostate Cancer (CRPC), Follicular Lymphoma (FL), Small Cell Lung Cancer (SCLC), Diffuse Large B-Cell Lymphoma (DLBCL)

    phase 1 other active

    1 trial

  10. C2321006

    Pfizer Australia Pty Ltd

    Small cell lung cancer, Castration-resistant prostate cancer, Follicular lymphoma

    phase 1 other active

    1 trial

  11. C2321007

    Pfizer Australia Pty Ltd

    small cell lung cancer (SCLC), castration resistant prostate cancer (CRPC), follicular lymphoma (FL)

    phase 1 other active

    1 trial

  12. C3421063

    Pfizer Australia Pty Ltd

    Type 2 Diabetes Mellitus, Obesity, Overweight management

    phase 1 other active

    1 trial

  13. C4151006

    Pfizer Australia Pty Ltd

    Inflammatory bowel disease

    phase 1 other active

    1 trial

  14. C4151008

    Pfizer Australia Pty Ltd

    Inflammatory bowel disease.

    phase 1 other active

    1 trial

  15. C4161006

    Pfizer Australia Pty Ltd

    (HR) -positive human epidermal growth factor receptor 2 (HER2) -negative breast cancer (BC), non-small cell lung cancer (NSCLC), ovarian cancer, and triple negative breast cancer (TNBC)

    phase 1 other active

    1 trial

  16. C4391010

    Pfizer Australia Pty Ltd

    metastatic/advanced breast cancer

    phase 1 other active

    1 trial

  17. C4541011

    Pfizer Australia Pty Ltd

    Older adults at risk of malnutrition

    phase 1 other active

    1 trial

  18. C4551007

    Pfizer Australia Pty Ltd

    locally advanced or metastatic ER+/HER2- breast cancer

    phase 1 other active

    1 trial

  19. C4551010

    Pfizer Australia Pty Ltd

    locally advanced or metastatic HR+/HER2- breast cancer

    phase 1 other active

    1 trial

  20. C4891037

    Pfizer Australia Pty Ltd

    ER+/HER2- breast cancer

    phase 1 other active

    1 trial

  21. C4891038

    Pfizer Australia Pty Ltd

    ER+/HER2- Breast Cancer

    phase 1 other active

    1 trial

  22. C4921002

    Pfizer Australia Pty Ltd

    Heart failure

    phase 1 other active

    1 trial

  23. C4921008

    Pfizer Australia Pty Ltd

    Heart Failure

    phase 1 other active

    1 trial

  24. C4951092

    Pfizer Australia Pty Ltd

    Migraine with or without aura

    phase 1 other active

    1 trial

  25. C5091010

    Pfizer Australia Pty Ltd

    severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

    phase 1 other active

    1 trial

  26. C5091029

    Pfizer Australia Pty Ltd

    Coronavirus disease 2019

    phase 1 other active

    1 trial

  27. C5171002

    Pfizer Australia Pty Ltd

    heart failure with preserved ejection fraction

    phase 1 other active

    1 trial

  28. C5381001

    Pfizer Australia Pty Ltd

    clonal hematopoiesis

    phase 1 other active

    1 trial

  29. C5381002

    Pfizer Australia Pty Ltd

    Clonal hematopoiesis

    phase 1 other active

    1 trial

  30. C5541002

    Pfizer Australia Pty Ltd

    Obesity, Overweight

    phase 1 other active

    1 trial

  31. C5661001

    Pfizer Australia Pty Ltd

    IgA nephropathy

    phase 1 other active

    1 trial

  32. C5671001

    Pfizer Australia Pty Ltd

    CCI

    phase 1 other active

    1 trial

  33. C5911001 - SGN-CD25V

    Pfizer Australia Pty Ltd

    Advanced lymphomas (classic Hodgkin lymphoma [cHL], peripheral T cell lymphoma [PTCL], and diffuse large B cell lymphoma [DLBCL]), Solid tumors (eg, NSCLC, HNSCC, and melanoma)

    phase 1 other active

    1 trial

  34. C5951001

    Pfizer Australia Pty Ltd

    advanced solid tumors

    phase 1 other active

    1 trial

  35. C5961001

    Pfizer Australia Pty Ltd

    RSV (Respiratory Syncytial Virus)

    phase 1 other active

    1 trial

  36. C6001001

    Pfizer Australia Pty Ltd

    Non-muscle invasive bladder cancer (NMIBC)

    phase 1 other active

    1 trial

  37. C6081001

    Pfizer Australia Pty Ltd

    KRAS mutated advanced solid tumors

    phase 1 other active

    1 trial

  38. C6341001

    Pfizer Australia Pty Ltd

    Rheumatoid arthritis and Systemic Lupus Erythematosus

    phase 1 other active

    1 trial

  39. Etrasimod Arginine Blue

    Pfizer Australia Pty Ltd

    Ulcerative Colitis and immune-mediated inflammatory disorders

    phase 1 small molecule active

    1 trial

  40. PF-07868489 Placebo, PF-07868489

    Pfizer Australia Pty Ltd

    Pulmonary Arterial Hypertension

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does First Biotech (Australia) have?

40 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.